CC
CORZ icon

Covalis Capital’s Core Scientific CORZ Stock Holding History

Covalis Capital’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40M Sell
1,563,413
-1,908,616
-55% -$44.9M 2.26% 11
2026
Q1 		$51.9M Sell
3,472,029
-1,869,884
-35% -$31.9M 3.2% 6
2025
Q4 		$77.8M Buy
+5,341,913
New +$93.1M 5.46% 3
2024
Q3 		– Sell
-35,363
Closed -$329K – 62
2024
Q2 		$329K Buy
+35,363
New +$181K 0.04% 60

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Covalis Capital's CORZ Position: Q2 2026 in Review

Covalis Capital reduced its Core Scientific (CORZ) stake by 55% in Q2 2026, selling an estimated $44.9M and leaving 1,563,413 shares worth $40M. The position accounts for 2.26% of the portfolio, ranked #11.

Covalis Capital first reported a position in CORZ in Q2 2024 and has held it in 4 quarters since. The position peaked at $77.8M in Q4 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Covalis Capital held 1,563,413 shares of Core Scientific worth $40M as of Q2 2026.
  • Covalis Capital sold 1,908,616 Core Scientific shares in Q2 2026, an estimated $44.9M.
  • Core Scientific made up 2.26% of Covalis Capital's portfolio in Q2 2026, its #11 holding.
  • Covalis Capital first reported a position in Core Scientific in Q2 2024 and has held it in 4 quarters since.
  • Covalis Capital's Core Scientific position peaked at $77.8M in Q4 2025.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Covalis Capital's 13F filing for Q2 2026, filed 13 Aug 2026.